Neurotrophic Keratitis: Detecting, Tracking, and Treating an Elusive...

Activity Chair

John D. Sheppard, MD, MMSc, FACS

President, Virginia Eye Consultants

Professor of Ophthalmology, Microbiology & Molecular Biology

Ophthalmology Residency Research Program Director

Eastern Virginia Medical School

Medical Director Lions Eye Bank of Eastern Virginia

Mid-Atlantic Medical Director, Eyecare Partners

Norfolk, VA

Faculty

Brandon D. Ayres, MD

Cornea Service

Co-Director of Cornea Fellowship

Wills Eye Hospital

Philadelphia, PA

Preeya K. Gupta, MD

Managing Director

Triangle Eye Consultants

Raleigh, NC

Adjunct Associate Professor of Ophthalmology

Cornea, Cataract, & Refractive Surgery

Tulane University

New Orleans, LA

Overview

The early diagnosis of neurotrophic keratitis (NK) is imperative to avoid such complications as ulceration, infection, stromal melting, perforation secondary to poor healing, and vision loss. Diagnosis can be challenging, because patients with early stages of NK may experience no symptoms and may therefore be diagnosed in later stages of the disease where epithelial damage has already begun. Current and emerging treatment options, when integrated optimally into management protocols, restore corneal sensitivity, and promote healing of the ocular surface, thus halting disease progression. In this CME activity, experts in the field review risk factors that contribute to the development of NK, discuss diagnostic and assessment techniques that improve the early detection and staging of disease, and evaluate the latest management and medical strategies for the optimal targeted treatment of patients with NK. This program will also include the unique, audience-engaging, educational gaming platform, Wheel of Knowledge.

Agenda

6:00 PM

Registration and Dinner

6:30 PM

Introduction and Pretest

John D. Sheppard, MD, MMSc

6:35 PM

Neurotrophic Keratitis: Burden, Pathophysiology, and Diagnosis

Brandon D. Ayres, MD

6:55 PM

Case Presentation: Patient Assessment and Diagnosis of Neurotrophic Keratitis

John D. Sheppard, MD, MMSc

7:00 PM

Treating Neurotrophic Keratitis: A Comparative Analysis

Preeya K. Gupta, MD

7:20 PM

Case Presentation: Treatment of Neurotrophic Keratitis

John D. Sheppard, MD, MMSc

7:25 PM

Wheel of Knowledge Challenge!

With your host, John D. Sheppard, MD, MMSc

7:45 PM

Posttest and Question & Answer

8:00 PM

Conclusion

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Recognize the burden of NK and risk factors that contribute to its development.

• Examine diagnostic and assessment techniques that improve the early detection and staging of NK.

• Evaluate the latest evidence about management strategies that facilitate corneal epithelial healing as well as medical advances that target the treatment of NK.

Target Audience

The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with or at risk for NK.

This continuing medical education activity is provided by Vindico Medical Education.

This activity is supported by an educational grant from Dompé US, Inc.

This activity is not affiliated with the official program of AAO 2022.

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico Medical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn Continuing Certification credits equivalent to the amount of CME credits claimed for the activity.

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from Vindico Medical Education, Office of Medical Affairs and Compliance.